Literature DB >> 6347598

Transient asystole associated with amphotericin B infusion.

H J DeMonaco, B McGovern.   

Abstract

Amphotericin B, a systemic antifungal agent, has not been associated with clinical evidence of cardiac toxicity. We report the case of a 76-year-old patient who developed transient asystole with cardiovascular collapse on two occasions, which coincided with infusion of amphotericin B. The patient was semicomatose and had candida septicemia and renal failure. Serum potassium and digoxin levels were elevated, and serum calcium was low when these episodes occurred. Subsequent postmortem examination revealed no gross evidence of cardiac disease apart from fungal vegetations on the aortic valve. A clear causal relationship between amphotericin B and transient asystole is not demonstrated, but a temporal association, confirmed with rechallenge, is documented in this patient. No similar cases were found in a review of the literature.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347598     DOI: 10.1177/106002808301700711

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  3 in total

1.  Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durations.

Authors:  E C Oldfield; P D Garst; C Hostettler; M White; D Samuelson
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  Atrioventricular block related to liposomal amphotericin B.

Authors:  Bruno Fernandes Sanches; Pedro Nunes; Helena Almeida; Mónica Rebelo
Journal:  BMJ Case Rep       Date:  2014-06-06

3.  Risk of ventricular dysrhythmias during 1-hour infusions of amphotericin B in patients with preserved renal function.

Authors:  W A Bowler; P J Weiss; H E Hill; K A Hoffmeister; R P Fleck; A R Blacky; E C Oldfield
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.